Skip to main content
Top
Published in: BMC Health Services Research 1/2016

Open Access 01-12-2016 | Research article

Advocacy for outpatient cardiac rehabilitation globally

Authors: Abraham Samuel Babu, Francisco Lopez-Jimenez, Randal J. Thomas, Wanrudee Isaranuwatchai, Artur Haddad Herdy, Jeffrey S. Hoch, Sherry L. Grace, in conjunction with the International Council of Cardiovascular Prevention and Rehabilitation (ICCPR)

Published in: BMC Health Services Research | Issue 1/2016

Login to get access

Abstract

Background

Cardiovascular diseases (CVD) are the leading cause of death globally. Cardiac rehabilitation (CR) is an evidence-based intervention recommended for patients with CVD, to prevent recurrent events and to improve quality of life. However, despite the proven benefits, only a small percentage of those would benefit from CR actually receive it worldwide.
This paper by the International Council of Cardiovascular Prevention and Rehabilitation forwards the groundwork for successful CR advocacy to achieve broader reimbursement, and hence implementation.

Methods

First, the results of the International Council’s survey on national CR reimbursement policies by government and insurance companies are summarized. Second, a multi-faceted approach to CR advocacy is forwarded. Finally, as per the advocacy recommendations, the economic impact of CVD and the corresponding benefits of CR and its cost-effectiveness are summarized. This provides the case for CR reimbursement advocacy.

Results

Thirty-one responses were received, from 25 different countries: 18 (58.1 %) were from high-income countries, 10 (32.4 %) from upper middle-income, and 3 (9.9 %) from lower middle-income countries. When asked who reimburses at least some portion of CR services in their country, 19 (61.3 %) reported the government, 17 (54.8 %) reported patients pay out-of-pocket, 16 (51.6 %) reported insurance companies, 12 (38.7 %) reported that it is shared between the patient and another source, and 7 (22.6 %) reported another source.

Conclusions

Many patients pay out-of-pocket for CR. CR reimbursement around the world is inconsistent and insufficient. Advocacy campaigns forwarding the CR cause, supported by the relevant literature, enlisting sources of support in a unified manner with an organized plan, are needed, and must be pursued persistently.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization; World Heart Federation; World Stroke Organization. Global atlas on CVD prevention and control. Geneva: WHO; 2011. http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/. Accessed 24 Sept 2015. World Health Organization; World Heart Federation; World Stroke Organization. Global atlas on CVD prevention and control. Geneva: WHO; 2011. http://​www.​who.​int/​cardiovascular_​diseases/​publications/​atlas_​cvd/​en/​.​ Accessed 24 Sept 2015.
2.
go back to reference Bloom DE, Cafiero, ET, Jané-Llopis E, Abrahams-Gessel S, Bloom, LR, Fathima, S, et al. The World Economic Forum and Harvard School of Public Health. The global economic burden of non-communicable diseases. 2011. http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf. Accessed 24 Sept 2015 Bloom DE, Cafiero, ET, Jané-Llopis E, Abrahams-Gessel S, Bloom, LR, Fathima, S, et al. The World Economic Forum and Harvard School of Public Health. The global economic burden of non-communicable diseases. 2011. http://​www3.​weforum.​org/​docs/​WEF_​Harvard_​HE_​GlobalEconomicBu​rdenNonCommunica​bleDiseases_​2011.​pdf. Accessed 24 Sept 2015
3.
go back to reference World Health Organization. The global burden of disease: 2004 update. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.Accessed 29 Sept 2015. World Health Organization. The global burden of disease: 2004 update. http://​www.​who.​int/​healthinfo/​global_​burden_​disease/​2004_​report_​update/​en/​.​Accessed 29 Sept 2015.
4.
go back to reference Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223.CrossRefPubMed Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223.CrossRefPubMed
5.
go back to reference Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–96.CrossRefPubMed Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–96.CrossRefPubMed
6.
go back to reference World Health Organization. Rehabilitation after cardiovascular disease with special emphasis on developing countries. WHO Technical Report Series No. 831. Geneva: WHO; 1993. http://apps.who.int/iris/bitstream/10665/38455/1/WHO_TRS_831.pdf Accessed 28 Sept 2015. World Health Organization. Rehabilitation after cardiovascular disease with special emphasis on developing countries. WHO Technical Report Series No. 831. Geneva: WHO; 1993. http://​apps.​who.​int/​iris/​bitstream/​10665/​38455/​1/​WHO_​TRS_​831.​pdf Accessed 28 Sept 2015.
7.
go back to reference Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al. Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update. Circulation. 2007;115:2675–82.CrossRefPubMed Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al. Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update. Circulation. 2007;115:2675–82.CrossRefPubMed
8.
go back to reference American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. 5th ed. Human Kinetics: USA; 2013. American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. 5th ed. Human Kinetics: USA; 2013.
9.
go back to reference Buckley JP, Furze G, Doherty P, Speck L, Connolly S, Hinton S, et al. British Association of Cardiovascular Prevention and Rehabilitation scientific statement: British standards and core components for cardiovascular disease prevention and rehabilitation. Heart. 2013;99:1069–71.CrossRefPubMed Buckley JP, Furze G, Doherty P, Speck L, Connolly S, Hinton S, et al. British Association of Cardiovascular Prevention and Rehabilitation scientific statement: British standards and core components for cardiovascular disease prevention and rehabilitation. Heart. 2013;99:1069–71.CrossRefPubMed
10.
go back to reference Woodruffe S, Neubeck L, Clark RA, Gray K, Ferry C, Finan J, et al. Australian Cardiovascular Health and Rehabilitation Association (ACRA) Core Components of Cardiovascular Disease Secondary Prevention and Cardiac Rehabilitation 2014. Heart Lung Circ. 2015;24:430–41.CrossRefPubMed Woodruffe S, Neubeck L, Clark RA, Gray K, Ferry C, Finan J, et al. Australian Cardiovascular Health and Rehabilitation Association (ACRA) Core Components of Cardiovascular Disease Secondary Prevention and Cardiac Rehabilitation 2014. Heart Lung Circ. 2015;24:430–41.CrossRefPubMed
11.
go back to reference Piepoli MF, Corrà U, Adamopoulos S, Benzer W, Bjarnason-Wehrens B, Cupples M, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol. 2014;21:664–81.CrossRefPubMed Piepoli MF, Corrà U, Adamopoulos S, Benzer W, Bjarnason-Wehrens B, Cupples M, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol. 2014;21:664–81.CrossRefPubMed
12.
go back to reference Pavy B, Iliou MC, Vergès-Patois B, Brion R, Monpère C, Carré F, et al. Exercise, Rehabilitation Sport Group (GERS); French Society of Cardiology. French Society of Cardiology guidelines for cardiac rehabilitation in adults. Arch Cardiovasc Dis. 2012;105:309–28.CrossRefPubMed Pavy B, Iliou MC, Vergès-Patois B, Brion R, Monpère C, Carré F, et al. Exercise, Rehabilitation Sport Group (GERS); French Society of Cardiology. French Society of Cardiology guidelines for cardiac rehabilitation in adults. Arch Cardiovasc Dis. 2012;105:309–28.CrossRefPubMed
13.
go back to reference Grace SL, Warburton DER, Stone JA, Sanderson B, Oldridge N, Jones J, et al. International charter on cardiovascular prevention and rehabilitation: A call for action. J Cardiopulm Rehabil Prev. 2013;33:128–31.CrossRefPubMedPubMedCentral Grace SL, Warburton DER, Stone JA, Sanderson B, Oldridge N, Jones J, et al. International charter on cardiovascular prevention and rehabilitation: A call for action. J Cardiopulm Rehabil Prev. 2013;33:128–31.CrossRefPubMedPubMedCentral
14.
go back to reference Turk-Adawi K, Grace SL. Narrative review comparing the benefits of, participation cardiac rehabilitation in high-, middle- and low-income countries. Heart Lung Circ. 2015;24:510–20.CrossRefPubMed Turk-Adawi K, Grace SL. Narrative review comparing the benefits of, participation cardiac rehabilitation in high-, middle- and low-income countries. Heart Lung Circ. 2015;24:510–20.CrossRefPubMed
15.
go back to reference Anderson L, Taylor RS. Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2014;12:CD011273. Anderson L, Taylor RS. Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2014;12:CD011273.
16.
go back to reference Thakur JS, Prinja S, Garg C, Mendis S, Menabde N. Social and economic implications of non-communicable diseases in India. Indian J Community Med. 2011;36(suppl):S13–22.CrossRefPubMedPubMedCentral Thakur JS, Prinja S, Garg C, Mendis S, Menabde N. Social and economic implications of non-communicable diseases in India. Indian J Community Med. 2011;36(suppl):S13–22.CrossRefPubMedPubMedCentral
18.
go back to reference Anchique Santos CV, Lopez-Jimenez F, Benaim B, Burdiat G, Fernandez Coronado R, Gonzalez G, et al. Cardiac rehabilitation in Latin America. Prog Cardiovasc Dis. 2014;57:268–75.CrossRefPubMed Anchique Santos CV, Lopez-Jimenez F, Benaim B, Burdiat G, Fernandez Coronado R, Gonzalez G, et al. Cardiac rehabilitation in Latin America. Prog Cardiovasc Dis. 2014;57:268–75.CrossRefPubMed
19.
go back to reference Cortes-Bergoderi M, Lopez-Jimenez F, Herdy AH, Zeballos C, Anchique C, Santibañez C, et al. Availability and characteristics of cardiovascular rehabilitation programs in South America. J Cardiopulm Rehabil Prev. 2013;33:33–41.CrossRefPubMed Cortes-Bergoderi M, Lopez-Jimenez F, Herdy AH, Zeballos C, Anchique C, Santibañez C, et al. Availability and characteristics of cardiovascular rehabilitation programs in South America. J Cardiopulm Rehabil Prev. 2013;33:33–41.CrossRefPubMed
20.
go back to reference Tramarin R, Ambrosetti M, De Feo S, Piepoli M, Riccio C. Griffo R; ISYDE-208 Investigators of the Italian Association for Cardiovascular Prevention, Rehabilitation and Prevention. The Italian Survey on Cardiac Rehabilitation-2008 (ISYDE-2008). Part 3. National availability and organization of cardiac rehabilitation facilities. Official report of the Italian Association for Cardiovascular Prevention, Rehabilitation and Epidemiology (IACPR-GICR). Monaldi Arch Chest Dis. 2008;70:175–205.PubMed Tramarin R, Ambrosetti M, De Feo S, Piepoli M, Riccio C. Griffo R; ISYDE-208 Investigators of the Italian Association for Cardiovascular Prevention, Rehabilitation and Prevention. The Italian Survey on Cardiac Rehabilitation-2008 (ISYDE-2008). Part 3. National availability and organization of cardiac rehabilitation facilities. Official report of the Italian Association for Cardiovascular Prevention, Rehabilitation and Epidemiology (IACPR-GICR). Monaldi Arch Chest Dis. 2008;70:175–205.PubMed
21.
go back to reference Curnier DY, Savage PD, Ades PA. Geographic distribution of cardiac rehabilitation programs in the United States. J Cardiopulm Rehabil. 2005;25:80–4.CrossRefPubMed Curnier DY, Savage PD, Ades PA. Geographic distribution of cardiac rehabilitation programs in the United States. J Cardiopulm Rehabil. 2005;25:80–4.CrossRefPubMed
22.
go back to reference Suaya J, Shepard D, Normand S, Ades P, Prottas J, Stason W. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007;116:1653–62.CrossRefPubMed Suaya J, Shepard D, Normand S, Ades P, Prottas J, Stason W. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007;116:1653–62.CrossRefPubMed
23.
go back to reference Kotseva K, Wood D, Backer GD, Bacquer DD. Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey. Eur J Prev Cardiol. 2013;20:817–26.CrossRefPubMed Kotseva K, Wood D, Backer GD, Bacquer DD. Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey. Eur J Prev Cardiol. 2013;20:817–26.CrossRefPubMed
24.
go back to reference Grace SL, Gravely-Witte S, Brual J, Monette G, Suskin N, Higginson L, et al. Contribution of patient and physician factors to cardiac rehabilitation enrollment: a prospective multilevel study. Eur J Cardiovasc Prev Rehabil. 2008;15:548–56.CrossRefPubMedPubMedCentral Grace SL, Gravely-Witte S, Brual J, Monette G, Suskin N, Higginson L, et al. Contribution of patient and physician factors to cardiac rehabilitation enrollment: a prospective multilevel study. Eur J Cardiovasc Prev Rehabil. 2008;15:548–56.CrossRefPubMedPubMedCentral
25.
go back to reference Levin LA, Perk J, Hedback B. Cardiac rehabilitation--a cost analysis. J Inten Med. 1991;230:427–34. Levin LA, Perk J, Hedback B. Cardiac rehabilitation--a cost analysis. J Inten Med. 1991;230:427–34.
26.
go back to reference Bjarnason- Wehrens B, McGee H, Zwisler AD, Piepoli M, Benzer W, Schmid JP, et al. Cardiac rehabilitation in Europe: Results from the European cardiac rehabilitation inventory survey. Eur J Cardiovasc Prev Rehabil. 2010;17:410–8.CrossRefPubMed Bjarnason- Wehrens B, McGee H, Zwisler AD, Piepoli M, Benzer W, Schmid JP, et al. Cardiac rehabilitation in Europe: Results from the European cardiac rehabilitation inventory survey. Eur J Cardiovasc Prev Rehabil. 2010;17:410–8.CrossRefPubMed
27.
go back to reference Suaya JA, Stason WB, Ades PA, Normand S-LT, Shepard DS. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol. 2009;54:25–33.CrossRefPubMed Suaya JA, Stason WB, Ades PA, Normand S-LT, Shepard DS. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol. 2009;54:25–33.CrossRefPubMed
28.
go back to reference Stewart R, Held C, Brown R, Vedin O, Hagstrom E, Lonn E, et al. Physical activity in patients with stable coronary heart disease: An international perspective. Eur Heart J. 2013;34:3286–93.CrossRefPubMedPubMedCentral Stewart R, Held C, Brown R, Vedin O, Hagstrom E, Lonn E, et al. Physical activity in patients with stable coronary heart disease: An international perspective. Eur Heart J. 2013;34:3286–93.CrossRefPubMedPubMedCentral
29.
go back to reference Thirapatarapong W, Thomas RJ, Pack Q, Sharma S, Squires RW. Commercial insurance coverage for outpatient cardiac rehabilitation in patients with heart failure in the United States. J Cardiopulm Rehabil Prev. 2014;34:386–9.CrossRefPubMed Thirapatarapong W, Thomas RJ, Pack Q, Sharma S, Squires RW. Commercial insurance coverage for outpatient cardiac rehabilitation in patients with heart failure in the United States. J Cardiopulm Rehabil Prev. 2014;34:386–9.CrossRefPubMed
30.
go back to reference Merrian Webster. http://www.merriam-webster.com/dictionary/advocacy Accessed 24 Sept 2015. Merrian Webster. http://​www.​merriam-webster.​com/​dictionary/​advocacy Accessed 24 Sept 2015.
31.
go back to reference Zoghbi WA, Duncan T, Antman E, Barbosa M, Champagne B, Chen D, et al. Sustainable development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce. Glob Heart. 2014;9:273–4.CrossRefPubMed Zoghbi WA, Duncan T, Antman E, Barbosa M, Champagne B, Chen D, et al. Sustainable development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce. Glob Heart. 2014;9:273–4.CrossRefPubMed
32.
go back to reference United Nations General Assembly. Open working group on Sustainable Developmental Goals. Geneva; 2014. https://sustainabledevelopment.un.org/sdgsproposal Accessed 26 Sept 2015. United Nations General Assembly. Open working group on Sustainable Developmental Goals. Geneva; 2014. https://​sustainabledevel​opment.​un.​org/​sdgsproposal Accessed 26 Sept 2015.
34.
go back to reference Oldridge N. Exercise-based cardiac rehabilitation in patients with coronary heart disease: meta-analysis outcomes revisited. Future Cardiol. 2012;8:729–51.CrossRefPubMed Oldridge N. Exercise-based cardiac rehabilitation in patients with coronary heart disease: meta-analysis outcomes revisited. Future Cardiol. 2012;8:729–51.CrossRefPubMed
35.
go back to reference American Association for Cardiovascular and Pulmonary Rehabilitation. https://www.aacvpr.org/Advocacy. Accessed 24 Sept 2015 American Association for Cardiovascular and Pulmonary Rehabilitation. https://​www.​aacvpr.​org/​Advocacy.​ Accessed 24 Sept 2015
36.
go back to reference World Heart Federation. http://www.world-heart-federation.org/what-we-do/advocacy/advocacy-toolkit/Accessed 24 Sept 2015 World Heart Federation. http://​www.​world-heart-federation.​org/​what-we-do/​advocacy/​advocacy-toolkit/​Accessed 24 Sept 2015
37.
go back to reference Public Health Agency of Canada. Economic burden of illness in Canada, 2005–2008. Ministry of Health, 2014. http://www.phac-aspc.gc.ca/publicat/ebic-femc/2005-2008/assets/pdf/ebic-femc-2005-2008-eng.pdf. Accessed 24 Sept 2015 Public Health Agency of Canada. Economic burden of illness in Canada, 2005–2008. Ministry of Health, 2014. http://​www.​phac-aspc.​gc.​ca/​publicat/​ebic-femc/​2005-2008/​assets/​pdf/​ebic-femc-2005-2008-eng.​pdf.​ Accessed 24 Sept 2015
38.
go back to reference Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M. European cardiovascular disease statistics. Sophia Antipolis: European Heart Network, Brussels, European Society of Cardiology; 2010. Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M. European cardiovascular disease statistics. Sophia Antipolis: European Heart Network, Brussels, European Society of Cardiology; 2010.
39.
go back to reference Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27:1610–9.CrossRefPubMed Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27:1610–9.CrossRefPubMed
40.
go back to reference Trogdon JG, Finkelstein EA, Nwaise IA, Tangka FK, Orenstein D. The economic burden of chronic cardiovascular disease for major insurers. Health Promot Pract. 2007;8:234–42.CrossRefPubMed Trogdon JG, Finkelstein EA, Nwaise IA, Tangka FK, Orenstein D. The economic burden of chronic cardiovascular disease for major insurers. Health Promot Pract. 2007;8:234–42.CrossRefPubMed
41.
go back to reference Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370:1929–38.CrossRefPubMed Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370:1929–38.CrossRefPubMed
42.
go back to reference Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood). 2007;26:13–24.CrossRefPubMedCentral Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood). 2007;26:13–24.CrossRefPubMedCentral
43.
go back to reference Sloan FA, Detsky AS, Kaplan RM, Dranove D, Weinstein MC, Pauly MV, et al. Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies. Sloan: Cambridge University Press; 1996. Sloan FA, Detsky AS, Kaplan RM, Dranove D, Weinstein MC, Pauly MV, et al. Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies. Sloan: Cambridge University Press; 1996.
44.
go back to reference Dunlay SM, Pack QR, Thomas RJ, Killian JM, Roger VL. Participation in cardiac rehabilitation, readmissions, and death after acute myocardial infarction. Am J Med. 2014;127:538–46.CrossRefPubMedPubMedCentral Dunlay SM, Pack QR, Thomas RJ, Killian JM, Roger VL. Participation in cardiac rehabilitation, readmissions, and death after acute myocardial infarction. Am J Med. 2014;127:538–46.CrossRefPubMedPubMedCentral
45.
go back to reference Engblom E, Korpilahti K, Hämäläinen H, Rönnemaa T, Puukka P. Quality of life and return to work 5 years after coronary artery bypass surgery. Long-term results of cardiac rehabilitation. J Cardiopulm Rehabil. 1997;17:29–36.CrossRefPubMed Engblom E, Korpilahti K, Hämäläinen H, Rönnemaa T, Puukka P. Quality of life and return to work 5 years after coronary artery bypass surgery. Long-term results of cardiac rehabilitation. J Cardiopulm Rehabil. 1997;17:29–36.CrossRefPubMed
46.
go back to reference Ades PA, Pashkow FJ, Nestor JR. Cost-effectiveness of cardiac rehabilitation after myocardial infarction. J Cardiopulm Rehabil Prev. 1997;17:222–31.CrossRef Ades PA, Pashkow FJ, Nestor JR. Cost-effectiveness of cardiac rehabilitation after myocardial infarction. J Cardiopulm Rehabil Prev. 1997;17:222–31.CrossRef
47.
go back to reference Johannesson M, Jonsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med. 1997;336:332–6.CrossRefPubMed Johannesson M, Jonsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med. 1997;336:332–6.CrossRefPubMed
48.
go back to reference Cleland JG, Walker A. Is medical treatment for angina the most cost-effective option? Eur Heart J. 1997;18(Suppl B):B35–42.CrossRefPubMed Cleland JG, Walker A. Is medical treatment for angina the most cost-effective option? Eur Heart J. 1997;18(Suppl B):B35–42.CrossRefPubMed
49.
go back to reference Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation. 2007;115:2398–409.CrossRefPubMed Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation. 2007;115:2398–409.CrossRefPubMed
50.
go back to reference Dendale P, Hansen D, Berger J, Lamotte M. Long-term cost-benefit ratio of cardiac rehabilitation after percutaneous coronary intervention. Acta Cardiol. 2008;63:451–6.CrossRefPubMed Dendale P, Hansen D, Berger J, Lamotte M. Long-term cost-benefit ratio of cardiac rehabilitation after percutaneous coronary intervention. Acta Cardiol. 2008;63:451–6.CrossRefPubMed
51.
go back to reference Weintraub WS, Boden WE, Zhang Z, et al. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes. 2008;1:12–20.CrossRefPubMed Weintraub WS, Boden WE, Zhang Z, et al. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes. 2008;1:12–20.CrossRefPubMed
52.
go back to reference Wilson K, Hettle R, Marbaix S, Diaz Cerezo S, Ines M, Santoni L, et al. An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy. Eur J Prev Cardiol. 2012;19:1173–83.CrossRefPubMed Wilson K, Hettle R, Marbaix S, Diaz Cerezo S, Ines M, Santoni L, et al. An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy. Eur J Prev Cardiol. 2012;19:1173–83.CrossRefPubMed
53.
go back to reference Smith T, Jordaens L, Theuns DA, van Dessel PF, Wilde AA, Hunink MG. The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis. Eur Heart J. 2013;34:211–9.CrossRefPubMed Smith T, Jordaens L, Theuns DA, van Dessel PF, Wilde AA, Hunink MG. The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis. Eur Heart J. 2013;34:211–9.CrossRefPubMed
Metadata
Title
Advocacy for outpatient cardiac rehabilitation globally
Authors
Abraham Samuel Babu
Francisco Lopez-Jimenez
Randal J. Thomas
Wanrudee Isaranuwatchai
Artur Haddad Herdy
Jeffrey S. Hoch
Sherry L. Grace
in conjunction with the International Council of Cardiovascular Prevention and Rehabilitation (ICCPR)
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1658-1

Other articles of this Issue 1/2016

BMC Health Services Research 1/2016 Go to the issue